专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

21. 发明申请

US20110130938A1 FUEL INJECTING CONTROL METHOD DURING COASTING OF VEHICLE 审中-公开
标题翻译：燃料注射控制方法
公开(公告)号：US20110130938A1
公开(公告)日：2011-06-02
申请号：US12836119
申请日：2010-07-14
申请人： Kil Hyeon Seok , Seunghee Han , Kwang Rak Lee , Soojin Kim , Tae Seong Lee
发明人： Kil Hyeon Seok , Seunghee Han , Kwang Rak Lee , Soojin Kim , Tae Seong Lee
IPC分类号： B60W10/06 , B60W10/18 , F02D41/30
CPC分类号： B60W10/06 , B60W10/196 , B60W30/146 , B60W30/18072 , B60W2520/10 , B60W2710/0616 , F02D11/106 , F02D31/007 , F02D31/009 , F02D41/021 , F02D41/022 , F02D41/123 , F02D2200/501 , Y02T10/76 , Y10T477/747
摘要： A fuel injecting control method during coasting of a vehicle, may include operating coasting mode when a coasting mode operation condition is satisfied, maintaining the coasting mode for a predetermined interval, injecting fuel according to engine speed, cutting fuel injecting when detected vehicle speed is equal to or more than a predetermined fuel cutting vehicle speed and less than a predetermined vehicle over speed, operating an assist brake when the detected vehicle speed is equal to or more than the predetermined vehicle over speed, and releasing the coasting mode when a releasing condition of the coasting mode is satisfied.
摘要翻译：在车辆滑行期间的燃料喷射控制方法可以包括当满足惯性行驶模式操作条件时的操作惯性模式，以预定间隔保持惯性模式，根据发动机速度喷射燃料，当检测到的车速相等时切断燃料喷射达到或大于预定燃料切割车速并小于预定车辆超速时，当检测到的车速等于或大于预定车辆超速时操作辅助制动器，并且当释放条件为滑行模式满足。

22. 发明申请

US20100136435A1 SECONDARY BATTERY AND MANUFACTURING METHOD OF THE SAME 有权
标题翻译：二次电池及其制造方法
公开(公告)号：US20100136435A1
公开(公告)日：2010-06-03
申请号：US12597938
申请日：2009-05-14
申请人： Sunghoon Yu , Jeong-Ju Cho , Soojin Kim , Soo-Hyun Ha
发明人： Sunghoon Yu , Jeong-Ju Cho , Soojin Kim , Soo-Hyun Ha
IPC分类号： H01M6/14 , H01M10/04
CPC分类号： H01M10/0565 , H01M2300/0085
摘要： Disclosed is a secondary battery including (i) a cathode; (ii) an anode; (iii) a separator; and (iv) a gel polymer electrolyte composition including an electrolyte solvent, an electrolyte salt, and a polymerizable monomer, wherein a polymerization initiator is coated or added on at least one battery device element in contact with the gel polymer electrolyte composition. Also, the secondary battery including a cathode, an anode, a separator, and a gel polymer electrolyte is manufactured by the steps of: coating or adding a polymerization initiator on/to at least one battery device element in contact with the gel polymer electrolyte; inserting the cathode, the anode, and the separator into a battery case; and forming the gel polymer electrolyte by injecting a gel polymer electrolyte composition including an electrolyte solvent, an electrolyte salt, and a polymerizable monomer into the battery case, and carrying out polymerization.
摘要翻译：公开了一种二次电池，其包括（i）阴极; （ii）阳极; （iii）分离器; 和（iv）包含电解质溶剂，电解质盐和可聚合单体的凝胶聚合物电解质组合物，其中在与凝胶聚合物电解质组合物接触的至少一个电池装置元件上涂布或加入聚合引发剂。此外，包括阴极，阳极，隔膜和凝胶聚合物电解质的二次电池通过以下步骤制造：在至少一个与凝胶聚合物电解质接触的电池器件元件上/涂覆聚合引发剂; 将阴极，阳极和隔膜插入电池壳体中; 并通过将包含电解质溶剂，电解质盐和可聚合单体的凝胶聚合物电解质组合物注射到电池壳体中并进行聚合来形成凝胶聚合物电解质。

23. 发明申请

US20050152981A1 Process for making sterile aripiprazole of desired mean particle size 审中-公开
标题翻译：制备所需平均粒径的无菌阿立哌唑的方法
公开(公告)号：US20050152981A1
公开(公告)日：2005-07-14
申请号：US10968481
申请日：2004-10-19
申请人： Margaret Gleeson , Soojin Kim , Donald Kientzler , San Kiang
发明人： Margaret Gleeson , Soojin Kim , Donald Kientzler , San Kiang
IPC分类号： B01D9/00 , C07D215/22 , C07D215/227 , A61K9/14
CPC分类号： A61J3/02 , B01D9/0009 , B01D9/005 , B01D9/0054 , B01D9/0063 , B01D9/0081 , B01J2/06 , C07D215/227
摘要： A process is provided for making sterile aripiprazole having an average particle size less than 100 microns but preferably greater than 25 microns employing an impinging jet crystallization procedure. The resulting bulk aripiprazole of desired particle size may be used to form a sterile freeze-dried aripiprazole formulation, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks.
摘要翻译：提供了一种制备平均粒径小于100微米但优选大于25微米的无菌阿立哌唑的方法，其采用冲击射流结晶方法。所得粒度的阿立哌唑可用于形成无菌冷冻干燥的阿立哌唑制剂，其在用水和肌内注射后，在至少约一周至多达八周的时间内释放阿立哌唑。

24. 发明授权

US06316438B1 Fused pyridopyridazine inhibitors of cGMP phosphodiesterase 有权
标题翻译： cGMP磷酸二酯酶的熔融吡啶并哒嗪抑制剂
公开(公告)号：US06316438B1
公开(公告)日：2001-11-13
申请号：US09526162
申请日：2000-03-15
申请人： Guixue Yu , John Macor , Soojin Kim , Hyei-Jha Chung , Michael Humora , Kishta Katipally , Yizhe Wang
发明人： Guixue Yu , John Macor , Soojin Kim , Hyei-Jha Chung , Michael Humora , Kishta Katipally , Yizhe Wang
IPC分类号： C07D23726
CPC分类号： C07D471/04
摘要： Compounds of the formula are useful as inhibitors of cGMP PDE especially Type 5.
摘要翻译：该化合物可用作cGMP PDE抑制剂，特别是5型

25. 发明授权

US08629171B2 Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt 有权
标题翻译：甲基（（1s）-1 - （（（2s）-2-（5-（4' - （2 - （（2s）-1 - （（2s）-2 - （（甲氧基羰基）氨基） -3-甲基丁酰基）-2-吡咯烷基）-1H-咪唑-5-基）-4-联苯基）-1H-咪唑-2-基）-1-吡咯烷基）羰基）-2-甲基丙基）氨基甲酸酯二盐酸盐
公开(公告)号：US08629171B2
公开(公告)日：2014-01-14
申请号：US12175104
申请日：2008-07-17
申请人： Soojin Kim , Qi Gao , Fukang Yang
发明人： Soojin Kim , Qi Gao , Fukang Yang
IPC分类号： A61K31/4178 , C07D233/54
CPC分类号： C07D403/04
摘要： The present disclosure generally relates to a crystalline form of methyl ((1S)-1-(((2S)-2-(5-(4′-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt. The present disclosure also generally relates to a pharmaceutical composition comprising a crystalline form, as well of methods of using a crystalline form in the treatment of Hepatitis C and methods for obtaining such crystalline form.
摘要翻译：本发明一般涉及（（1S）-1 - （（1S）-2-（5-（4' - （2 - （（2S）-1 - （（2S）（（甲氧基羰基）氨基）-3-甲基丁酰基）-2-吡咯烷基）-1H-咪唑-5-基）-4-联苯基）-1H-咪唑-2-基）-1-吡咯烷基）羰基）-2-甲基丙基）氨基甲酸酯二盐酸盐。本公开还通常涉及包含结晶形式的药物组合物，以及在治疗丙型肝炎中使用结晶形式的方法以及获得这种结晶形式的方法。

26. 发明授权

US08609670B2 Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma 有权
公开(公告)号：US08609670B2
公开(公告)日：2013-12-17
申请号：US13592664
申请日：2012-08-23
申请人： Pascale A. J. Pouzet , Peter Nickolaus , Ulrike Werthmann , Rogelio Perez Frutos , Bing-Shiou Yang , Soojin Kim , Jason Alan Mulder , Nitinchandra D. Patel , Chris Hugh Sananayake , Thomas Gabriel Tampone , Xudong Wei
发明人： Pascale A. J. Pouzet , Peter Nickolaus , Ulrike Werthmann , Rogelio Perez Frutos , Bing-Shiou Yang , Soojin Kim , Jason Alan Mulder , Nitinchandra D. Patel , Chris Hugh Sananayake , Thomas Gabriel Tampone , Xudong Wei
IPC分类号： A61K31/519
CPC分类号： C07D495/04 , A61K31/519 , A61K45/06 , C07B2200/13 , C07C213/00 , C07D401/04 , C07C215/42
摘要： The invention relates to novel piperidino-dihydrothienopyrimidine sulfoxides of formula I, wherein Ring A is a 6-membered aromatic ring which may optionally comprise one or two nitrogen atoms and wherein R is Cl and wherein R may be located either in the para-, meta- or ortho-position of Ring A, wherein S* is a sulphur atom that represents a chiral center, and all pharmaceutically acceptable salts, enantiomers and racemates, hydrates and solvates thereof and the use of these compounds for the treatment of inflammatory or allergic diseases of the respiratory tract such as COPD or asthma.

27. 发明授权

US08524399B2 Non-aqueous electrolyte and secondary battery comprising the same 有权
标题翻译：非水电解质和包含该非水电解质的二次电池
公开(公告)号：US08524399B2
公开(公告)日：2013-09-03
申请号：US12672789
申请日：2008-08-08
申请人： Soojin Kim , Jeong-Ju Cho
发明人： Soojin Kim , Jeong-Ju Cho
IPC分类号： H01M6/18
CPC分类号： H01M10/0567 , H01M10/052 , H01M2300/0025
摘要： Disclosed is a non-aqueous electrolyte including an electrolyte salt and an electrolyte solvent, the non-aqueous electrolyte further including a compound containing both a carboxy group and a (meth)acrylic group, and a secondary battery including the non-aqueous electrolyte. The use of the compound containing both the carboxy group and the (meth)acrylic group as a component for an electrolyte significantly reduces the increase of battery thickness at high temperature storage.
摘要翻译：公开了包含电解质盐和电解质溶剂的非水电解质，所述非水电解质还包含含有羧基和（甲基）丙烯酸基的化合物，以及包含所述非水电解质的二次电池。含有羧基和（甲基）丙烯酸基团的化合物作为电解质的组分的使用显着降低了高温储存时电池厚度的增加。

28. 发明授权

US08420819B2 Process for optimizing the particle size of an active pharmaceutical ingredient by crystallization 有权
标题翻译：通过结晶优化活性药物成分的粒径的方法
公开(公告)号：US08420819B2
公开(公告)日：2013-04-16
申请号：US12788562
申请日：2010-05-27
申请人： Soojin Kim
发明人： Soojin Kim
IPC分类号： C07D471/04
CPC分类号： C07D471/04
摘要： A process to crystallize uniform small particles of a compound of Formula (I) with narrow particle size distribution and excellent powder characteristics that facilitate the formulation process and optimal drug product performance, wherein the compound of Formula (I) is: wherein R1, R2, and R3 are as described herein.
摘要翻译：使具有窄粒度分布和促进配制过程和最佳药物产品性能的优异粉末特性的式（I）化合物的均匀小颗粒结晶的方法，其中式（I）化合物为：其中R1，R2，和R3如本文所述。

29. 发明申请

US20120142715A1 POLYMORPH OF [4,6-BIS(DIMETHYLAMINO)-2-(4-BENZYL)PYRIMIDIN-5-YL] 审中-公开
标题翻译： [4,6-BIS（二甲基氨基）-2-（4-苄基）嘧啶-5-YL]
公开(公告)号：US20120142715A1
公开(公告)日：2012-06-07
申请号：US13382366
申请日：2010-07-01
申请人： Soojin Kim
发明人： Soojin Kim
IPC分类号： A61K31/505 , A61P11/06 , A61P11/02 , C07D239/48 , A61P11/00
CPC分类号： C07D239/48
摘要： Provided is a crystalline form of the ethylenediamine salt of [4,6-bis(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)pyrimidin-5-yl]acetic acid, processes for its preparation, pharmaceutical compositions comprising it, and methods of its use for treating, preventing, or ameliorating one or more symptoms of a CRTH2-mediated disorder or disease.
摘要翻译：本发明提供[4,6-双（二甲基氨基）-2-（4 - {[4-（三氟甲基）苯甲酰基]氨基}苄基）嘧啶-5-基]乙酸的乙二胺盐的结晶形式，制剂，包含它的药物组合物及其用于治疗，预防或改善CRTH2介导的病症或疾病的一种或多种症状的方法。

30. 发明申请

US20110268697A1 Hepatitis C Virus Inhibitors 审中-公开
标题翻译：丙型肝炎病毒抑制剂
公开(公告)号：US20110268697A1
公开(公告)日：2011-11-03
申请号：US13176970
申请日：2011-07-06
申请人： Soojin Kim , Qi Gao , Fukang Yang
发明人： Soojin Kim , Qi Gao , Fukang Yang
IPC分类号： A61K31/4178 , A61K38/21 , A61P31/14 , A61K38/20 , A61K31/7088 , A61K31/437 , C07D403/14 , A61K31/7056
CPC分类号： C07D401/14 , C07D403/14
摘要： The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
摘要翻译：本公开涉及用于治疗丙型肝炎病毒（HCV）感染的化合物，组合物和方法。还公开了含有这些化合物的药物组合物和使用这些化合物治疗HCV感染的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式